au.\*:("BOTTA, Mario")
Results 1 to 4 of 4
Selection :
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion : Results of a phase II study on 31 consecutive patientsCASTAGNETO, Bruno; ZAI, Silvia; MUTTI, Luciano et al.Lung cancer. 2001, Vol 31, Num 2-3, pp 303-310, issn 0169-5002Article
Single-agent gemcitabine in previously untreated elderly patients with advanced bladder carcinoma: Response to treatment and correlation with the comprehensive geriatric AssessmentCASTAGNETO, Bruno; ZAI, Silvia; MARENCO, Daniela et al.Oncology. 2004, Vol 67, Num 1, pp 27-32, issn 0030-2414, 6 p.Article
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesotheliomaBETTI, Marta; NERI, Monica; BOTTA, Mario et al.International journal of hygiene and environmental health. 2009, Vol 212, Num 3, pp 322-329, issn 1438-4639, 8 p.Article
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclinesBERRUTI, Alfredo; SPERONE, Paola; DE LENA, Mario et al.Journal of clinical oncology. 2000, Vol 18, Num 19, pp 3370-3377, issn 0732-183XArticle